July 30, 2018
Beximco’s fifth ANDA approved in USA
Beximco Pharmaceuticals got approval from the US Food and Drug Administration (FDA), for its Nadolol tablets, a generic equivalent of Bristol-Myers Squibb’s…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
July 30, 2018
Apricus Biosciences merges with Seelos Therapeutics
Apricus Biosciences will merge with Seelos Therapeutics, Inc., a privately-held biotechnology company, in an all-stock transaction, it announced on Monday,…
July 26, 2018
Positive data supports product opportunities for XF-73 in dermal infection indications
Destiny Pharma’s first of two Phase 1 safety clinical studies of testing XF-73’s potential to cause dermal irritation, as Destiny’s…
July 26, 2018
Neurodegeneration may be tied to drainage issues in the brain
PureTech Health’s new internal programme focused on treating central nervous system (CNS) disorders via modulation of the brain’s lymphatic system,…
July 26, 2018
WuXi’s API production site in china passes USFDA’s inspection
WuXi STA Pharmaceutical’s Active Pharmaceutical Ingredient (API) production site in China, at Jinshan, Shanghai, has passed its fourth inspection from…
July 25, 2018
resTORbio with positive results in Phase 2b trial of inhibitor RTB101
PureTech Health’s independent affiliate, resTORbio reported positive topline results from its Phase 2b clinical study with TORC1 inhibitor, that enrolled…
July 25, 2018
Midatexh Pharma expects 16% revenues increase in first half of the year
Midatech Pharma said in its trading update it remains on track to meet market expectations for 2018, as it expects…
July 24, 2018
Cheplapharm to deal Atacand in 28 European countries, AZ nets $200M
AstraZeneca will sell the commercial rights to prescription medicine for the treatment of heart failure and hypertension, Atacand and Atacand Plus…
July 24, 2018
Idorsia expects non-GAAP operating expenses for 2018 to be around 390 million Swiss francs
Idorsia operated with US GAAP 155 million CHP ($156M) net loss for the first half of 2018. According to the…
July 23, 2018
Novartis extends agreement with the WHO for the donation of Egaten for the treatment of liver fluke
Novartis has signed a renewed memorandum of understanding with the World Health Organization (WHO) to extend its drug donation for Egaten…